


Searching News Database: Dauntless Pharmaceuticals
HSMN NewsFeed - 30 Jan 2018
FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly
FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly
HSMN NewsFeed - 21 Jul 2015
Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement
Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement
